<DOC>
	<DOCNO>NCT00000301</DOCNO>
	<brief_summary>The purpose study empirically test series medication : 1 ) determine medication 's efficacy treatment cocaine abuse/dependence ; 2 ) find effective dose range medication . In study , amantadine test . ''</brief_summary>
	<brief_title>Rapid Evaluation Amantadine Treatment Cocaine Abuse/Dependence - 4</brief_title>
	<detailed_description>16-week participation plus 2 weekk lead-in period . Participants assign randomly placebo amantadine . Participants attend group meeting 3 times/week</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>M/F , age 1865. cocaine dependence accord DMSIV criterion . Selfreported use within last 30 day . Agreeable condition study sign informed consent . Psychiatric disorder require medication therapy , history seizure . Pregnant and/or nursing woman . Dependence ETOH benzodiazepine sedativehypnotics . Acute hepatitis . Other medical condition deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Amantadine</keyword>
	<keyword>Cocaine</keyword>
	<keyword>Pharmacotherapy</keyword>
	<keyword>Outpatient</keyword>
</DOC>